Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Blood

• Publication date

  1992-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V80.3.688.BLOODJOURNAL803688PMID 1638022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6.

  1991cited by this paper
• Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesis.

  1991cited by this paper
• Is thrombopoietin interleukin 6?

  1991cited by this paper
• Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates.

  1991cited by this paper
• Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression.

  1991cited by this paper
• Interleukin 6 is a differentiation factor for human megakaryocytes in vitro

  1990cited by this paper
• Thrombopoietic activity of human interleukin‐6

  1990cited by this paper
• Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment.

  1990cited by this paper
• In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

  1990cited by this paper
• Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

  1990cited by this paper
• The role of interleukin 6 and interleukin 1 in megakaryocyte development.

  1989cited by this paper
• Regulation of megakaryocyte development by interleukin-6.

  1989cited by this paper
• The role of interleukin 6 and interleukin 1 in megakaryocyte development.

  1989cited by this paper
• A single low dose of human recombinant interleukin 1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia.

  1989cited by this paper
• Interleukin-6 is a potent thrombopoietic factor in vivo in mice.

  1989cited by this paper
• Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha.

  1988cited by this paper
• Species of the Genus Papio (Cercopithecidae, Primates) as Subjects of Biomedical Research: II. Quantitative Characteristics of Contemporary Use of Baboon Species in Medical and Biological Investigations

  1988cited by this paper
• Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

  1987cited by this paper
• Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts.

  1979cited by this paper

• New opportunities and current challenges using animal models for the discovery of novel countermeasures for acute radiation syndrome

  2025cites this paper
• Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

  2024cites this paper
• Acute Radiation Effects, the H-ARS in the Non-human Primate: A Review and New Data for the Cynomolgus Macaque with Reference to the Rhesus Macaque

  2021cites this paper
• Hematopoietic Recovery using Multi-Cytokine Therapy in 8 Patients Presenting Radiation-Induced Myelosuppression after Radiological Accidents

  2021cites this paper
• Chemical Synthesis of Proteins Through Native Chemical Ligation of Peptide Hydrazides

  2021cites this paper
• CpG-Oligodeoxynucleotides Improved Irradiation-Induced Injuries by G-CSF and IL-6 Up-Regulation

  2017cites this paper
• Nonhuman primates as models for the discovery and development of radiation countermeasures

  2017cites this paper
• A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures

  2017cites this paper
• Haematopoietic, Antioxidant and Membrane Stabilizing Property of Diallyl Disulphide in Irradiated Mice.

  2016cites this paper
• Modulatory Effects of Carica papaya (Linn.) on Electron Beam Radiation Induced Hematological Suppression and Biochemical Alterations in Swiss Albino Mice

  2016cites this paper
• Revisiting Biomarkers of Total-Body and Partial-Body Exposure in a Baboon Model of Irradiation

  2015cites this paper
• Animal models for acute radiation syndrome drug discovery

  2015cites this paper
• [Investigation of the effect of ibuprofen on wound healing in experimental Staphylococcus aureus soft tissue infections].

  2015cites this paper
• Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation

  2015cites this paper
• Useful Radiation Dose Biomarkers for Early Identification of Partial-body Exposures

  2014cites this paper
• Semisynthesis of biologically active glycoforms of the human cytokine interleukin 6.

  2014cites this paper
• RED CELLS , IRON , AND ERYTHROPOIESIS The effects of the anti-hepcidin Spiegelmer NOX-H 94 on in fl ammation-induced anemia in cynomolgus monkeys

  2013cites this paper
• Expression Level of IL-6 Secreted by Bone Marrow Stromal Cells in Mice with Aplastic Anemia

  2013cites this paper
• The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.

  2013cites this paper
• treated dogs Relative reactivity of platelets from thrombopoietin- and interleukin-6-

  2013cites this paper
• long-term follow-up of hematopoiesis after irradiation prevents nonhuman primates from myelosuppression: growth and development factor, and interleukin-3 in combination soon Single administration of stem cell factor, FLT-3 ligand, megakaryocyte

  2013cites this paper
• Structural characterization and radioprotection of bone marrow hematopoiesis of two novel polysaccharides from the root of Angelica sinensis (Oliv.) Diels.

  2012cites this paper
• Assessment of Total- and Partial-Body Irradiation in a Baboon Model: Preliminary Results of a Kinetic Study Including Clinical, Physical, and Biological Parameters

  2012cites this paper
• Hematological Changes as Prognostic Indicators of Survival: Similarities Between Gottingen Minipigs, Humans, and Other Large Animal Models

  2011cites this paper
• neonatal and adult fibroblasts and endothelial cells Regulation of interleukin-11 protein and mRNA expression in

  2011cites this paper
• Etude des effets des rayonnements ionisants sur la niche hématopoïétique et traitement du syndrome aigu d'irradiation par thérapie génique chez le macaque irradié à forte dose

  2011cites this paper
• cytokine (SC-55494) after radiation-induced bone marrow aplasia Acceleration of hematopoietic reconstitution with a synthetic

  2011cites this paper
• placebo- controlled, randomized phase Ib study ovarian cancer before and after chemotherapy: a multicentric Thrombopoietic effects and toxicity of interleukin-6 in patients with

  2011cites this paper
• Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity

  2008cites this paper
• Development of Radiation Countermeasures

  2008cites this paper
• Correlation between levels of TNF-α and IL-6 and hematological involvement in SLE Egyptian Patients with lupus nephritis

  2007cites this paper
• A Phase I Clinical, Pharmacologic, and Biologic Study of Thrombopoietin and Granulocyte Colony-Stimulating Factor in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Recurrent or Refractory Solid Tumors: A Children's Oncology Group Experience

  2005cites this paper
• MÉCANISMES DE RÉGULATION DU FLT3-LIGAND APRÈS IRRADIATION

  2005cites this paper
• Cytokine-based treatment of accidentally irradiated victims and new approaches.

  2005cites this paper
• Reactive thrombocytosis associated with a pheochromocytoma

  2005cites this paper
• Cancer Treatment and Research

  2005cites this paper
• Nonhuman primates are relevant models for research in hematology, immunology and virology.

  2005cites this paper
• Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis.

  2004cites this paper
• Inflammatory Reaction and Changes in Expression of Coagulation Proteins on Lung Endothelial Cells after Total-Body Irradiation in Mice

  2003cites this paper
• Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors

  2003cites this paper
• des Universitätsklinikums Hamburg-Eppendorf Medizinische Klinik und Poliklinik I

  2002cites this paper
• Effects of Recombinant Human Interleukin-6 in Cancer Patients : A Phase 1-11 Study

  2002cites this paper
• Regulation of Interleukin-l 1 Protein and mRNA Expression in Neonatal and Adult Fibroblasts and Endothelial Cells

  2002cites this paper
• Characterization of the Acute Inflammatory Response after Irradiation in Mice and its Regulation by Interleukin 4 (Il4)

  2001cites this paper
• Inflammatory response to abdominal irradiation stimulates hemopoiesis.

  2001cites this paper
• A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional

  2001cites this paper
• Evaluation of human hemopoietic stem cell assays for transplantation and gene therapy

  2001cites this paper
• Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects.

  2000cites this paper
• Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation.

  1999cites this paper
• The Reduction of In Vitro Radiation‐Induced Fas‐Related Apoptosis in CD34+ Progenitor Cells by SCF, FLT‐3 Ligand, TPO, and IL‐3 in Combination Resulted in CD34+ Cell Proliferation and Differentiation

  1999cites this paper
• Biomedical research: its mission within the French Military Medical Service.

  1999cites this paper
• Clinical Applications of Cytokines and Growth Factors

  1999cites this paper
• The Effects of Multilineage Cytokines on Platelet Recovery

  1999cites this paper
• Preferential liver irradiation enhances hematopoiesis through a thrombopoietin-independent mechanism.

  1999cites this paper
• Voltammetric measurement of blood nitric oxide in irradiated rats.

  1999cites this paper
• The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia.

  1998cites this paper
• TNF, IL-1 and IL-6 in circulating blood after total-body and localized irradiation in rats.

  1998cites this paper
• Thrombopoietic factors potentially useful in the treatment of acute leukemia.

  1998cites this paper
• Accelerated recovery of irradiation-induced bone marrow depression by fibroblast-mediated interleukin 6 gene therapy in combination with bone marrow transplantation in mice.

  1998cites this paper
• Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.

  1997cites this paper
• A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.

  1997cites this paper
• Hematopoietic effects of recombinant human interleukin-3 and interleukin-6

  1997cites this paper
• Efficacy of Mpl Ligands and Other Thrombopoietic Cytokines in Animal Models

  1997cites this paper
• University of Groningen Hematopoietic effects of recombinant human interleukin-3 and interleukin-6 Veldhuis,

  1997cites this paper
• Recombinant cytokines and hematopoietic growth factors in allogeneic and autologous bone marrow transplantation.

  1997cites this paper
• Relative reactivity of platelets from thrombopoietin- and interleukin-6-treated dogs.

  1996cites this paper
• Recombinant Human Ligand for MPL, Megakaryocyte Growth and Development Factor (MGDF), Stimulates Thrombopoiesis in Vivo in Normal and Myelosuppressed Baboons

  1996cites this paper
• Interleukin-6 and megakaryocytopoiesis: an update

  1996cites this paper
• [Therapeutic approaches of hematopoietic syndrome following accidental total whole body irradiation].

  1996cites this paper
• Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.

  1996cites this paper
• Cytokine–Induced Alteration of Platelet and Hemostatic Function

  1996cites this paper
• Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancer.

  1996cites this paper
• IL‐6‐induced anaemia in rats: possible pathogenetic implications for anaemia observed in chronic inflammations

  1996cites this paper
• Interleukin 6 in diseases: cause or cure?

  1996cites this paper
• Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.

  1996cites this paper
• Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia.

  1996cites this paper
• Accelerated platelet reconstitution following transplantation of bone marrow cells derived from IL-6-treated donor mice

  1996cites this paper
• Potential use of recombinant human interleukin-6 in clinical oncology.

  1996cites this paper
• The tolerability and pharmacology of interleukin-6 administered in combination with GM-CSF or G-CSF in the rhesus monkey.

  1995cites this paper
• Recombinant Human Interleukin-6 Accelerates In-Virto Megakaryocytopoiesis and Platelet Recovery Post Autologous Peripheral Blood Stem Cell Transplantion

  1995cites this paper
• Interleukin 6 Modulates AChE Activity in CNS Neurons

  1995cites this paper
• Control of thrombocytopoiesis: current state of the art.

  1995cites this paper
• Preclinical safety studies with recombinant human interleukin 6 (rhil‐6) in the primate callithrix jacchus (marmoset): Comparison with studies in rats

  1995cites this paper
• Effects of Cytokine Administration on Human Hematopoiesis in SCID-hu Mice

  1995cites this paper
• The role of cytokines in modulating neonatal myelopoiesis and host defense.

  1995cites this paper
• Structure, stability and biological properties of a N-terminally truncated form of recombinant human interleukin-6 containing a single disulfide bond.

  1995cites this paper
• Author's Reply to Letter to the Editor

  1995cites this paper
• Erythropoiesis and erythropoietin in multiple myeloma.

  1995cites this paper
• Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates.

  1995cites this paper
• Comment on the review: haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia.

  1995cites this paper
• The regulation of megakaryocytopoiesis.

  1995cites this paper
• Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients.

  1995cites this paper
• Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia.

  1995cites this paper
• In vivo effects of interleukin‐11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis

  1995cites this paper
• Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation.

  1995cites this paper
• Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer.

  1995cites this paper
• A phase I/II trial of recombinant human interleukin‐6 in patients with aplastic anaemia

  1995cites this paper
• Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.

  1995cites this paper
• Recombinant human interleukin-6: safety issues of a pleiotropic growth factor.

  1995cites this paper
• Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study.

  1995cites this paper